Local Institution - 0328

Houston, Texas 77025

0 studies enrolling now · 1 studies all time

What they study most

Relapsed or Refractory Multiple Myeloma

Studies at this site

• A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) — Running, not enrolling